28372-1-AP

antibody from Proteintech Group

Targeting: KIF2C CT139, KNSL6, MCAK

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

28372-1-AP

Provider

Proteintech Group

Product name

KIF2C antibody

Antibody type

Polyclonal

Description

KIF2C antibody (Cat. #28372-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, Mouse , Rat and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

KIF18B Modulates SKP2 Ubiquitination to Promote Aerobic Glycolysis and Osteosarcoma Progression.

Liu H, Guo X, Lu C, Lu D
International journal of molecular sciences 2026 Apr 2;27(7)

---

Consensus Integration of Multiomics Data With Machine Learning Algorithms Reveals Heterogeneous Molecular Subtypes and Enables Personalized Treatment Strategies for Hepatocellular Carcinoma.

Jin Z, Fang K, Zhang X, Song M, Jiang H, Liu Y
Human mutation 2025;2025:9967779

---

Reprogramming neuroblastoma by diet-enhanced polyamine depletion.

Cherkaoui S, Turn CS, Yuan Y, Lu W, Yang L, McBride MJ, Eigenmann C, Allen GE, Panasenko OO, Zhang L, Vu A, Liu K, Li Y, Gandhi OH, Surrey LF, Kienast SD, Leidel SA, Wierer M, White E, Rabinowitz JD, Hogarty MD, Morscher RJ
Nature 2025 Oct;646(8085):707-715

---

Identification of lactylation-related biomarkers in HNSC by integrating machine learning and Spatial transcriptomics analysis.

Wang PY, Zheng YP, Zhao YL
Discover oncology 2025 Nov 5;16(1):2042

---

The RNA-stability-independent role of the RNA m(6)A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance.

Liu T, Yang D, Wei Q, Wang Y, Tian L, Liu X, Yang Y, Luo Q, Xu J, Liu Y, Yang C, Zuo X, Luo F, Luo X, Zhao H, Li L, Xu J, Yu J, Ma S, Yu J, Yi P
Molecular cell 2025 Jun 19;85(12):2320-2336.e9

---

The role of glucocorticoids in hepatocellular carcinoma through integrated bioinformatics analysis and experimental validation.

Wang A, Yin X, Li S, Fu Y, Jiang T, Fu J
Scientific reports 2025 Jul 25;15(1):27094

---

USP36 suppresses breast cancer cell ferroptosis by regulating the ubiquitination and stability of KIF2C.

Chen Y, Hong S, Wu F, Xu S, Yang Y, Xu J
Biochemical pharmacology 2025 Dec;242(Pt 2):117196

---

miR-4484 suppresses hepatocellular carcinoma progression via targeting KIF2C.

Lin J, Cai Y, Chen Z, Ma J, Zhao K
RNA biology 2025 Dec;22(1):1-20

---

Identification and dissection of prostate cancer grounded on fatty acid metabolism-correlative features for predicting prognosis and assisting immunotherapy.

Zheng Y, Peng Y, Gao Y, Yang G, Jiang Y, Zhang G, Wang L, Yu J, Huang Y, Wei Z, Liu J
Computational biology and chemistry 2025 Apr;115:108323

---

KIF2C promotes oral squamous cell carcinoma progression via PLK1 upregulation: implications for biomarker development and therapeutic targeting.

Wang C, Su Y, Shi J, Feng G
Journal of molecular histology 2025 Apr 28;56(3):146

---

Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis.

Guo K, Yang J, Jiang R, Ren X, Liu P, Wang W, Zhou S, Wang X, Ma L, Hu Y
Pharmaceuticals (Basel, Switzerland) 2024 Sep 28;17(10)

---

Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor.

Cai L, Shi B, Zhu K, Zhong X, Lai D, Wang J, Tou J
Scientific reports 2023 Sep 16;13(1):15404

---

Development and validation of a vesicle-mediated transport-associated gene signature for predicting prognosis and immune therapy response in hepatocellular carcinoma.

Liu ZY, Li YH, Li BW, Xin L
Journal of cancer research and clinical oncology 2023 Nov;149(14):13211-13230

---

KIF2C is a Biomarker Correlated With Prognosis and Immunosuppressive Microenvironment in Human Tumors.

Zhang X, Li Y, Hu P, Xu L, Qiu H
Frontiers in genetics 2022;13:891408

---

Multi-omics analysis of kinesin family member 2C in human tumors: novel prognostic biomarker and tumor microenvironment regulator.

Zhang B, Liu P, Li Y, Hu Q, Li H, Pang X, Wu H
American journal of cancer research 2022;12(11):4954-4976

---

Identification of biomarkers for the transition from low-grade glioma to secondary glioblastoma by an integrated bioinformatic analysis.

Zhao L, Zhang J, Liu Z, Zhao P
American journal of translational research 2020;12(4):1222-1238